184 related articles for article (PubMed ID: 17001308)
1. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
Streicher KL; Yang ZQ; Draghici S; Ethier SP
Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
[TBL] [Abstract][Full Text] [Related]
2. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.
Yang ZQ; Streicher KL; Ray ME; Abrams J; Ethier SP
Cancer Res; 2006 Dec; 66(24):11632-43. PubMed ID: 17178857
[TBL] [Abstract][Full Text] [Related]
3. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
[TBL] [Abstract][Full Text] [Related]
4. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
[TBL] [Abstract][Full Text] [Related]
5. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer.
Rutkovsky AC; Yeh ES; Guest ST; Findlay VJ; Muise-Helmericks RC; Armeson K; Ethier SP
BMC Cancer; 2019 May; 19(1):491. PubMed ID: 31122207
[TBL] [Abstract][Full Text] [Related]
7. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
Yang ZQ; Albertson D; Ethier SP
Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903
[TBL] [Abstract][Full Text] [Related]
10. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy.
Voutsadakis IA
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32987805
[TBL] [Abstract][Full Text] [Related]
11. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
[TBL] [Abstract][Full Text] [Related]
12. Amplification of 8p11.23 in cancers and the role of amplicon genes.
Voutsadakis IA
Life Sci; 2021 Jan; 264():118729. PubMed ID: 33166592
[TBL] [Abstract][Full Text] [Related]
13. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon.
Still IH; Hamilton M; Vince P; Wolfman A; Cowell JK
Oncogene; 1999 Jul; 18(27):4032-8. PubMed ID: 10435627
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Bernard-Pierrot I; Gruel N; Stransky N; Vincent-Salomon A; Reyal F; Raynal V; Vallot C; Pierron G; Radvanyi F; Delattre O
Cancer Res; 2008 Sep; 68(17):7165-75. PubMed ID: 18757432
[TBL] [Abstract][Full Text] [Related]
15. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
[TBL] [Abstract][Full Text] [Related]
16. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
18. A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.
Mahmood SF; Gruel N; Chapeaublanc E; Lescure A; Jones T; Reyal F; Vincent-Salomon A; Raynal V; Pierron G; Perez F; Camonis J; Del Nery E; Delattre O; Radvanyi F; Bernard-Pierrot I
Carcinogenesis; 2014 Mar; 35(3):670-82. PubMed ID: 24148822
[TBL] [Abstract][Full Text] [Related]
19. Engineering targeted chromosomal amplifications in human breast epithelial cells.
Springer S; Yi KH; Park J; Rajpurohit A; Price AJ; Lauring J
Breast Cancer Res Treat; 2015 Jul; 152(2):313-21. PubMed ID: 26099605
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional analysis of 9p24 amplified genes in human breast cancer.
Wu J; Liu S; Liu G; Dombkowski A; Abrams J; Martin-Trevino R; Wicha MS; Ethier SP; Yang ZQ
Oncogene; 2012 Jan; 31(3):333-41. PubMed ID: 21666724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
